U.S. Markets open in 13 hrs, 56 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 6.43 09:30 AM EST | |
|---|---|---|
| Day High | 6.79 03:58 PM EST |
|
| Range | 0.36 |
| Volume | 214,401 | |
|---|---|---|
| 30-Day Avg Vol | 287,000 |
|
| Difference | -25.30% |
| Market Cap | 259.59 M | |
|---|---|---|
| Mkt Cap Chg | 7.27 M |
| Shares Out | 38.28 M | |
|---|---|---|
| % Shrs Traded | 0.56% | |
| 1yr EPS Est | -0.472 |
| 52-Wk Low | 4.98 | |
|---|---|---|
| 52-Wk High | 10.10 |
|
| Range | 5.12 |
| Prev Close | 6.59 11/5/09 | |
|---|---|---|
| Today's Open | 6.53 | |
| Change | -0.91% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.25 M |
| Revenue (LFY) | 17.15 M | |
|---|---|---|
| Earnings (LFY) | -18.23 M | |
| Earnings (MRQ) | -8.61 M | |
| Next Earn Est | -0.21 | |
| Next Earnings | 11/09/2009 |
|
| EPS (TTM) | -0.77 | |
| 1yr EPS Growth | 38.70% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -14.00 | |
| PEG Ratio | -0.70 | |
| Return on Equity | -11.30 | |
| Beta | 0.90 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cypress Bioscience explores the swampy waters of functional somatic syndromes, a group of chronic symptom-based disorders that are, on the whole, poorly understood. The biotech company's primary target ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.21 11/9/09 | — — |
—
—
|
| Last Quarter | -0.24 6/30/09 | -0.23 6/30/09 |
0.01
Beat
|
| 2 Quarters Ago | 0.123 3/31/09 | -0.24 3/31/09 |
-0.363
Missed
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 5.81 M | 17.16 M |
| Gross Profit | 5.31 M | 16.89 M |
| Operating Income | -9.10 M | -10.38 M |
| Net Income | -8.61 M | -18.23 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts